AbbVie (ABBV)
(Delayed Data from NYSE)
$196.30 USD
-2.25 (-1.13%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $196.54 +0.24 (0.12%) 7:24 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, AbbVie Inc. has a market cap of $350.75B, which represents its share price of $198.55 multiplied by its outstanding shares number of 1.77B. As a large-cap company, ABBV's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ABBV 196.30 -2.25(-1.13%)
Will ABBV be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ABBV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ABBV
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
ABBV: What are Zacks experts saying now?
Zacks Private Portfolio Services
J&J Expects Better Top-Line Growth in 2H: Can It Achieve the Goal?
How Did Skyrizi and Rinvoq Sales Contribute to AbbVie's Q2 Results?
Economy Heating Up on PCE for June
Other News for ABBV
Trump Threatens Pharma With Potential 250% Tariffs In 18 Months: 'We Want Pharmaceuticals Made In Our Country'
Evolus plunges after Q2 miss, guidance cut; Needham downgrades
Trump ups pharma tariff threat to 250%